Related Experiment Video

Updated: Apr 18, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.6K

CD44 regulates pancreatic cancer invasion through MT1-MMP

Wei Jiang1, Yaqing Zhang1, Kevin T Kane1

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan.

Molecular Cancer Research : MCR
|January 9, 2015
PubMed
Abstract

Insights

CD44 is crucial for pancreatic cancer metastasis by inducing epithelial-mesenchymal transition (EMT). This involves the Snail1 transcription factor and MMP14, forming a CD44-Snail-MMP axis that drives invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Pancreatic cancer exhibits high mortality due to rapid metastasis and treatment resistance.
  • The molecular mechanisms underlying pancreatic cancer cell invasion remain incompletely understood.

Purpose of the Study:

  • To investigate the role of CD44 in regulating pancreatic cancer metastasis.
  • To elucidate the molecular pathway linking CD44 to cancer cell invasion and epithelial-mesenchymal transition (EMT).

Main Methods:

  • In vitro and in vivo experimental approaches were utilized.
  • Analysis of CD44 expression and its downstream targets in pancreatic cancer cells.
  • Investigation of the role of Snail1 and MMP14 in the metastatic process.

Main Results:

  • CD44 expression on pancreatic cancer cells is essential for inducing EMT and activating invasion.
  • CD44 regulates the expression of the transcription factor Snail1 (SNAI1).
  • Snail1 controls the expression of membrane-bound metalloproteinase MMP14 (MT1-MMP), which is critical for invasion.

Conclusions:

  • The CD44-Snail1-MMP axis is identified as a key regulator of EMT and invasion in pancreatic cancer.
  • CD44 and MT1-MMP represent potential therapeutic targets for pancreatic cancer treatment.
  • Existing small molecule or biologic inhibitors could be explored for targeting this pathway.

More Related Videos

A Preclinical Murine Model of Hepatic Metastases06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

30.9K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

4.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K